Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreBringing together unparalleled healthcare data, advanced analytics, innovative technologies, and healthcare expertise to create intelligent connections that speed the development and commercialization of innovative medicines to improve patient lives.
Learn MoreAccelerate digital innovation to enable smarter decisions that reduce cost, modernize patient and consumer engagement, and improve health outcomes.
Learn MoreYour world is unique – and quite different from pharma. In the U.S., decision-making has shifted from individual physicians to integrated networks--GPOs, IDNs and payers. These groups have heightened the focus on proving your solution’s value, demanding outcomes analyses and putting pressure on pricing.
Learn MoreFor government agencies and organizations at every level—from federal or national to regional and local—Big Data can have a huge impact on public health.
Learn MoreA curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the United States healthcare market.
LEARN MOREGet the latest insights on our life sciences, healthcare, and medical technology solutions in the United States. Follow our blog today!
LEARN MOREExternal comparators (ECs) built from real world data (RWD), and the resulting real world evidence (RWE), are increasingly being applied to support initial regulatory approval and labeling changes for marketed products.
Join us for this webinar where we will discuss recommendations from the FDA draft guidance and success factors for getting ECs right in oncology.
Key Topics:
Leanne Li, MPH, MBA
Sr. Principal, Real World Strategy and Innovation, U.S. Real World Solutions, IQVIA
Mayank Raizada, MS
Principal, Regulatory Science & Strategy, IQVIA
David Alsadius, MD, PhD
Sr. Medical Director, Medical Strategy Lead for Oncology, IQVIA
Mohsin Shah, MBBS, MSCE
Consultant Epidemiologist, Epidemiology and Drug Safety, U.S. Real World Solutions, IQVIA